Harvest Portfolios Group Inc. Has $56.23 Million Holdings in Danaher Co. (NYSE:DHR)

Harvest Portfolios Group Inc. increased its position in Danaher Co. (NYSE:DHR) by 1.2% in the third quarter, HoldingsChannel reports. The firm owned 202,263 shares of the conglomerate’s stock after acquiring an additional 2,465 shares during the period. Danaher accounts for about 1.9% of Harvest Portfolios Group Inc.’s investment portfolio, making the stock its 17th biggest holding. Harvest Portfolios Group Inc.’s holdings in Danaher were worth $56,233,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. CarsonAllaria Wealth Management Ltd. acquired a new stake in shares of Danaher in the second quarter worth $25,000. nVerses Capital LLC purchased a new stake in Danaher in the 2nd quarter worth about $25,000. MFA Wealth Advisors LLC acquired a new stake in Danaher during the 2nd quarter worth about $51,000. Financial Connections Group Inc. purchased a new position in Danaher during the 2nd quarter valued at about $51,000. Finally, Western Pacific Wealth Management LP acquired a new position in shares of Danaher in the 1st quarter valued at about $55,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 10.90% of the company’s stock.

Danaher Price Performance

NYSE DHR opened at $254.99 on Wednesday. Danaher Co. has a 1 year low of $192.35 and a 1 year high of $281.70. The company has a fifty day simple moving average of $266.16 and a 200 day simple moving average of $260.84. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a market cap of $184.17 billion, a P/E ratio of 47.74, a P/E/G ratio of 4.55 and a beta of 0.85.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the company earned $2.02 earnings per share. On average, sell-side analysts predict that Danaher Co. will post 7.51 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.42%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is currently 20.61%.

Wall Street Analyst Weigh In

Several research firms recently commented on DHR. Stifel Nicolaus raised their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Barclays decreased their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 23rd. Evercore ISI upped their price target on shares of Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. Raymond James reduced their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Finally, Wells Fargo & Company initiated coverage on Danaher in a research report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 target price on the stock. Six investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.